Feature Channels
Stem Cells
Filters:
ScienceChannels:Keywords: |
EMBARGOEDA reporter's PressPass is required to access this story until the embargo expires on 5/19/2013 1:00 PM EDT |
5/19/2013 1:00 PM EDT
Released to reporters: 5/17/2013 11:00 AM EDT
|
MedicineChannels:Keywords: |
Stem-Cell-Based Strategy Boosts Immune System in Mice
Raising hopes for cell-based therapies, UC San Francisco researchers have created the first functioning human thymus tissue from embryonic stem cells in the laboratory. The researchers showed that, in mice, the tissue can be used to foster the development of white blood cells the body needs to mount healthy immune responses and to prevent harmful autoimmune reactions. |
Embargo expired: 5/16/2013 12:00 PM EDT
Released: 5/14/2013 4:00 PM EDT
University of California, San Francisco (UCSF) |
MedicineChannels:Keywords: |
New Data for the Treatment of Preeclampsia: Preclinical Research Shows PLX Cells May Be Effective in Treating Preeclampsia
According to findings from an early preclinical study led by Brett Mitchell, PhD, an Associate Professor of Internal Medicine in the Cardiovascular Research Institute (CVRI) at Texas A&M University College of Medicine, there is evidence that administrating placenta-derived cells may help reverse the symptoms associated with preeclampsia in a matter of days after dosing with no harmful effects to mother or baby. |
Released: 5/16/2013 11:40 AM EDT
Pluristem Therapeutics Incorporated |
ScienceChannels:Keywords: |
Salk Researchers Chart Epigenomics of Stem Cells That Mimic Early Human Development
Scientists have long known that control mechanisms known collectively as “epigenetics” play a critical role in human development, but they did not know precisely how alterations in this extra layer of biochemical instructions in DNA contribute to development. |
Released: 5/9/2013 12:00 PM EDT
Salk Institute for Biological Studies |
MedicineChannels:Keywords: |
UCLA Stem Cell Researchers Move Toward Treatments for Rare Genetic Nerve DiseaseUCLA researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have used induced pluripotent stem cells (iPSC) to advance disease-in-a-dish modeling of a rare genetic disorder, Ataxia Telangiectasia. Their discovery shows positive effects of drugs that may lead to effective new treatments for the neurodegenerative disease. iPSC are made from patient skin cells rather than from embryos and can become any type of cells in the laboratory. |
Embargo expired: 5/7/2013 11:00 AM EDT
Released: 5/6/2013 3:30 PM EDT
University of California, Los Angeles (UCLA), Health Sciences |
ScienceChannels:Keywords: |
Divide and Define: Clues to Understanding How Stem Cells Produce Different Kinds of Cells
The human body contains trillions of cells, all derived from a single cell, or zygote, made by the fusion of an egg and a sperm. That single cell contains all the genetic information needed to develop into a human, and passes identical copies of that information to each new cell as it divides into the many diverse types of cells that make up a complex organism like a human being. |
Embargo expired: 5/5/2013 1:00 PM EDT
Released: 5/2/2013 11:00 AM EDT
University of Michigan |
MedicineChannels:Keywords: |
Human Brain Cells Developed in Lab, Grow in Mice
A key type of human brain cell developed in the laboratory grows seamlessly when transplanted into the brains of mice, UC San Francisco researchers have discovered, raising hope that these cells might one day be used to treat people with Parkinson’s disease, epilepsy, and possibly even Alzheimer’s disease, as well as and complications of spinal cord injury such as chronic pain and spasticity. |
Released: 5/3/2013 5:15 PM EDT
University of California, San Francisco (UCSF) |
MedicineChannels:Keywords: |
Epilepsy Cured in Mice Using Brain Cells
Epilepsy that does not respond to drugs can be halted in adult mice by transplanting a specific type of cell into the brain, UC San Francisco researchers have discovered, raising hope that a similar treatment might work in severe forms of human epilepsy. |
Released: 5/3/2013 5:00 PM EDT
University of California, San Francisco (UCSF) |
MedicineChannels:Keywords: |
Making Cancer Less CancerousResearchers at Johns Hopkins have identified a gene that, when repressed in tumor cells, puts a halt to cell growth and a range of processes needed for tumors to enlarge and spread to distant sites. The researchers hope that this so-called “master regulator” gene may be the key to developing a new treatment for tumors resistant to current drugs. |
Embargo expired: 5/2/2013 5:00 PM EDT
Released: 4/29/2013 9:00 AM EDT
Johns Hopkins Medicine |
ScienceChannels: |
Adult Cells Transformed Into Early-Stage Nerve Cells, Bypassing the Pluripotent Stem Cell StageA University of Wisconsin-Madison research group has converted skin cells from people and monkeys into a cell that can form a wide variety of nervous-system cells — without passing through the do-it-all stage called the induced pluripotent stem cell, or iPSC. |
Embargo expired: 5/2/2013 12:00 PM EDT
Released: 4/29/2013 1:00 PM EDT
University of Wisconsin-Madison |
